“…It has been advocated that the allogenic effect can be attributed to a direct activation of C-nociceptors by osmolality or pH of the solution or activation by release of endogenous mediators such as histamine, kinin, and other substances mediating inflammation [15,16]. The efficacy and stability of the mixed drug solutions should be evaluated before clinical application because, once mixed, they may become unstable [17] or may be precipitated. In addition, in the presence of other adjuvant treatment, they may lose efficacy and/or potency.…”